Revolution Medicines' pancreatic cancer drug daraxonrasib succeeds in trial
Medicines of the revolution'The pancreatic cancer drug was successful in a highly anticipated Phase 3 trial, nearly doubling the typical…
Biotechnology and pharmaceuticals
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
Ben Sasse highlights daraxonrasib for pancreatic cancer
Medicines of the revolution could be on the cusp of a breakthrough. The company hopes to soon publish results from…
Trump administration finalizes Medicare Advantage payment rate
Centers for Medicare and Medicaid Services Administrator Mehmet Oz speaks during an event sponsored by the Action for Progress Coalition,…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Eli Lilly reaches agreement to bring AI-developed medicines to the global market
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
Menstrual product prices soar due to inflation and tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina, on October 29, 2024. Ruvic…